A retrospective descriptive study of colorectal large or intermediate cell lymphoma in cats managed with surgical resection and/or medical management.

Combining surgical resection with chemotherapy may significantly improve survival in cats with colorectal lymphoma.

This retrospective study aimed to evaluate the outcomes of cats with intermediate- or large-cell colorectal lymphoma treated with surgical resection and/or chemotherapy. The study included 11 cats, with common clinical signs such as haematochezia, hyporexia, diarrhoea, and weight loss. Treatment strategies varied, leading to an overall median survival time of 177 days. Notably, cats receiving both surgery and chemotherapy had a median survival time of 972 days, with two cats surviving over 20 months post-diagnosis. These findings suggest that multimodal treatment, combining surgical resection and chemotherapy, may offer significant survival benefits for cats with colorectal lymphoma. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/40579833/?utm_source=openai))

This summary was distilled by AI and may occasionally misinterpret data. Confirm critical details with the primary literature before clinical application.